In a study of Medicare beneficiaries, researchers from Brigham and Women’s Hospital found that one year after hospitalization for heart failure, 6 percent of patients had progressed to dialysis.
Novo signs up for nearly a dozen cardiometabolic programs out of Valo Health
Novo Nordisk will broaden its cardiometabolic pipeline by pairing up with machine learning and drug discovery startup Valo Health in a deal that builds on